AXISCADES Technologies Limited (AXISCADES)
Transcript of Earnings Webinar - Q1 FY27
AI summary
- Q1 FY27 consolidated revenue 346 Cr (+42% y-y), net loss 14.8 Cr due to divestment costs
- Retained business revenue 183 Cr (+94% y-y), normalized EBITDA 41 Cr (11.8% margin), normalized PAT 20.2 Cr
- Defense revenue 125 Cr (+112% y-y), EBITDA 13 Cr; assured order visibility 4,557 Cr over ~3 years
- XiDA revenue 49.5 Cr (+63% y-y), EBITDA margin ~30%, added 2 global tech customers
- Aerospace manufacturing revenue 6.1 Cr; acquisition expected Q2 FY27 to add 180 Cr revenue, 22% EBITDA margin
- Divestment proceeds of ~920 Cr to fund manufacturing build and acquisitions without equity dilution
- FY27 revenue guidance 1,377 Cr continuing operations; EBITDA target 270 Cr; PAT ~135 Cr
- Capex aligned with divestment inflows; bridge financing ~100-150 Cr planned
- Strategic partnerships in space and manufacturing ongoing; announcements expected soon
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AXISCADES — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AXISCADES to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on AXISCADES Technologies Limited
Important.
The summary above is generated automatically from AXISCADES Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.